Last reviewed · How we verify

HALOFANTRINE HYDROCHLORIDE

FDA-approved approved Small molecule Quality 5/100

HALOFANTRINE HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 1992).

At a glance

Generic nameHALOFANTRINE HYDROCHLORIDE
ModalitySmall molecule
PhaseFDA-approved
First approval1992

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about HALOFANTRINE HYDROCHLORIDE

What is HALOFANTRINE HYDROCHLORIDE?

HALOFANTRINE HYDROCHLORIDE is a Small molecule drug.

When was HALOFANTRINE HYDROCHLORIDE approved?

HALOFANTRINE HYDROCHLORIDE was first approved on 1992.

What development phase is HALOFANTRINE HYDROCHLORIDE in?

HALOFANTRINE HYDROCHLORIDE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing